Application of drug delivery systems for the controlled delivery of growth factors to treat nervous system injury
- PMID: 30148412
- PMCID: PMC6300096
- DOI: 10.1080/15476278.2018.1491183
Application of drug delivery systems for the controlled delivery of growth factors to treat nervous system injury
Abstract
Nervous system injury represent the most common injury and was unique clinical challenge. Using of growth factors (GFs) for the treatment of nervous system injury showed effectiveness in halting its process. However, simple application of GFs could not achieve high efficacy because of its rapid diffusion into body fluids and lost from the lesion site. The drug delivery systems (DDSs) construction used to deliver GFs were investigated so that they could surmount its rapid diffusion and retain at the injury site. This study summarizes commonly used DDSs for sustained release of GFs that provide neuroprotection or restoration effects for nervous system injury.
Keywords: drug delivery systems; growth factors; nervous system injury; neurogenesis.
Similar articles
-
Novel drug delivery systems for releasing growth factors to the CNS: focus on Alzheimer's and Parkinson's diseases.Mini Rev Med Chem. 2014;14(7):557-66. doi: 10.2174/1389557514666140622205058. Mini Rev Med Chem. 2014. PMID: 24958218 Review.
-
Controlled release of growth factors for regenerative medicine.Curr Pharm Des. 2015;21(12):1627-32. doi: 10.2174/1381612821666150115154602. Curr Pharm Des. 2015. PMID: 25594403 Review.
-
Materials Science and Design Principles of Growth Factor Delivery Systems in Tissue Engineering and Regenerative Medicine.Adv Healthc Mater. 2019 Jan;8(1):e1801000. doi: 10.1002/adhm.201801000. Epub 2018 Nov 6. Adv Healthc Mater. 2019. PMID: 30398700 Review.
-
Externally triggered release of growth factors - A tissue regeneration approach.J Control Release. 2021 Apr 10;332:74-95. doi: 10.1016/j.jconrel.2021.02.015. Epub 2021 Feb 16. J Control Release. 2021. PMID: 33600882 Review.
-
Growth Factor Delivery Systems for Tissue Engineering and Regenerative Medicine.Adv Exp Med Biol. 2018;1078:245-269. doi: 10.1007/978-981-13-0950-2_13. Adv Exp Med Biol. 2018. PMID: 30357627 Review.
References
-
- Rumpel S. Supporting recovery from brain injury. Science (New York, NY). 2018;360:30–31. - PubMed
-
- Nakatomi H, Kuriu T, Okabe S, Yamamoto S, Hatano O, Kawahara N, Tamura A, Kirino T, Nakafuku M. Regeneration of hippocampal pyramidal neurons after ischemic brain injury by recruitment of endogenous neural progenitors. Cell. 2002;110:429–441. - PubMed
-
- Matsushima GK, Taniike M, Glimcher LH, Grusby MJ, Frelinger JA, Suzuki K, Ting JP. Absence of MHC class II molecules reduces CNS demyelination, microglial/macrophage infiltration, and twitching in murine globoid cell leukodystrophy. Cell. 1994;78:645–656. - PubMed
-
- Barrientos S, Stojadinovic O, Golinko MS, Brem H, Tomic-Canic M. Growth factors and cytokines in wound healing. Wound Repair Regenerat. 2008;16:585–601. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources